MolPort-002-130-141

ACCESS ALL DATA, CHEMISTRY

ACTIVE PHARMA INGREDIENTS

31 API Suppliers, 19 USDMF, 14 CEP/COS, 6 EU WC, 5 NDC API, 17 Listed Suppliers, $ API Reference Price

DEVELOPMENTS

1 Drugs in Development

1 Drugs in Development

INTERMEDIATES

5 API Suppliers

5 API Suppliers

FINISHED DOSAGE FORMULATIONS

177 FDF Dossiers, 118 FDA Orange Book, 5 Europe, 19 Canada, 6 Australia, 8 South Africa, 21 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

TABLET;ORAL - 10MG, TABLET;ORAL - 1MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, TABLET;ORAL - 2.5MG, TABLET;ORAL - 2MG, TABLET;ORAL - 3MG, TABLET;ORAL - 4MG, TABLET;ORAL - 5MG, TABLET;ORAL - 6MG, TABLET;ORAL - 7.5MG

RELATED EXCIPIENT COMPANIES

2 Rochem International Inc, 21 SPI Pharma, 2 DKSH, 1 Jai Radhe Sales, 1 Boai NKY Pharmaceuticals Ltd, 12 Gangwal Healthcare, 1 Nanjing Well Pharmaceutical, 1 Pfanstiehl, 1 ACG Worldwide, 2 Actylis, 8 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd, 10 BASF, 10 Corel Pharma Chem, 6 DFE Pharma, 7 Gangwal Chemicals, 5 Ideal Cures Pvt Ltd, 4 Ingredion Pharma Solutions, 37 Kerry, 3 Kima Chemical, 6 Lonza Capsugel, 14 Microlex e.U, 2 Novo Excipients, 2 Pharmatrans-Sanaq, 6 Pluviaendo, 3 Prachin Chemical, 1 Qianhao Chemical (Hebei) Co., Ltd, 1 Qualicaps, 16 Roquette, 7 Seppic, 6 Shanghai Shenmei Pharmaceutical Technology Co., Ltd, 1 Shijiazhuang Huaxu Pharmaceutical, 10 Sigachi Industries, 2 The Dow Chemical Company, 1 Ulanqab Kema New Material, 3 Vasa Pharmachem

EXCIPIENTS BY APPLICATIONS

83 Fillers, Diluents & Binders, 41 Direct Compression, 40 Coating Systems & Additives, 23 Granulation, 23 Controlled & Modified Release, 21 Disintegrants & Superdisintegrants, 20 Co-Processed Excipients, 17 Thickeners and Stabilizers, 16 Chewable & Orodispersible Aids, 15 Taste Masking, 11 Lubricants & Glidants, 9 Parenteral, 8 Solubilizers, 6 Film Formers & Plasticizers, 5 Empty Capsules, 5 API Stability Enhancers, 4 Emulsifying Agents, 4 Vegetarian Capsules, 3 Coloring Agents, 3 Rheology Modifiers

DIGITAL CONTENT

3 DATA COMPILATION #PharmaFlow, 11 NEWS #PharmaBuzz

GLOBAL SALES INFORMATION

2 US Medicaid Prescriptions, 21 Finished Drug Prices, 2 Annual Reports

MARKET PLACE

11 APIs, 12 FDF Dossiers

REF. STANDARDS & IMPURITIES

2 EDQM, 1 Others

ANALYTICAL

1 BioAnalytical Methods, 2 Analytical Methods

$ Xls

Filters

Xls

USFDA APPLICATION NUMBER - 9218 / DOSAGE - TABLET;ORAL - 1MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

Ingredient Name	Basis of Strength	Strength
Active Ingredient/Active Moiety
warfarin sodium(UNII: 6153CWM0CL) (warfarin - UNII:5Q7ZVV76EI)	warfarin sodium	2.5mg

Inactive Ingredients

Ingredient Name	A-S Medication Solutions	A-S Medication Solutions LLC	Aphena Pharma Solutions - Tennessee, Inc.	Avera McKennan Hospital	Bristol-Myers Squibb Pharma Company	Cardinal Health	Lake Erie Medical & Surgical Supply DBA Quality Care Products LLC	REMEDYREPACK INC.	REMEDYREPACK INC.	Bristol-Myers Squibb Holdings Pharma, Ltd. Liability Company
aluminum hydroxide(5QB0T2IUN0)
ALUMINUM HYDROXIDE-GLYCINE (2:1)(E9L1NA800E)
ANHYDROUS LACTOSE(3SY5LH9PMK)
barium sulfate(25BB7EKE2E)
D&C RED NO. 6(481744AI4O)
D&C Yellow No. 10(35SW5USQ3G)
FD&C BLUE NO. 1(H3R47K3TBD)
FD&C BLUE NO. 2(L06K8R7DQK)
FD&C RED NO. 40(WZB9127XOA)
FD&C Yellow No. 6(H77VEI93A8)
LACTOSE MONOHYDRATE(EWQ57Q8I5X)
lactose(J2B2A4N98G)
LACTOSE, UNSPECIFIED FORM(J2B2A4N98G)
MAGNESIUM STEARATE(70097M6I30)
mannitol(3OWL53L36A)
sodium chloride(451W47IQ8X)
sodium hydroxide(55X04QC32I)
sodium phosphate, dibasic, heptahydrate(70WT22SF4B)
sodium phosphate, monobasic, monohydrate(593YOG76RN)
starch, tapioca(24SC3U704I)

Drug Product Composition: MolPort-002-130-141